AXXAM

Event

Society for Neuroscience (SfN) Annual Meeting

Michael Campognone, SVP, BD – North America

Jean-Francois RollandDirector, Biological Sciences

Axxam at the Society for Neuroscience (SfN) Annual Meeting

Axxam will attend the Society for Neuroscience (SfN) Annual Meeting, the world’s largest event dedicated to neuroscience research and innovation.
Our team will showcase two scientific posters focused on advancing therapeutic strategies for neurodegenerative diseases such as Parkinson’s and Alzheimer’s.

We welcome partners, collaborators, and researchers to connect with us during the conference.

Our Expertise in Neuroscience Drug Discovery

Axxam supports neuroscience drug discovery through:

  • Human iPSC-based disease models

  • Mechanism-of-action studies

  • Electrophysiology (Lysopatch™ and APC)

  • Custom cellular assay development

  • High-throughput and high-content screening platforms

Our integrated approach accelerates early-stage therapeutic programs from target to hit.

Scientific Posters Presented by Axxam

🧬  Elucidating aggregation: a cell-based plate reader assay to model α-Synuclein pathology in neurodegeneration (Poster PSTR438.06) – G. Maresca¹, A. Cinti¹, D. Del Prete¹, S. Viganò¹, F. Ricci¹,M. Campognone², L. Redaelli¹, T. Grammatopoulos³, *J. Rolland¹

🧠Harnessing Organelles as Targets for Treatment in Neurodegenerative Diseases (Poster PSTR438.03)S. Donato¹, T. Sorbo¹, M. Saggioro¹, D. Bardelli¹, S. Corallino¹,D. Del Prete¹, D. Presutti¹, M. Paina¹, S. Martin¹, A. Rossetti¹,
S. Cainarca¹, A. Mondini¹, F. Ricci¹, *M. Campognone², J. Rolland¹

Meet us!

Our Director of Biological Sciences and our SVP Business Development will be available at the event to explore:

  • Collaborations in neuroscience drug development

  • Assay development and screening activities

  • Translational models for CNS disorders

📩 Book a meeting with our team: CONTACT US

Scroll to Top